US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist

7.140
+0.020+0.28%

Close Aug 23 16:00 ET

7.150
+0.010+0.14%

Post 20:02 ET

35.09MMarket Cap-183P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atara Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 17.328M	--
--	2024/Q3	-- / 35.168M	--
--	2024/Q2	28.640M / 37.092M	--
--	2024/Q1	27.357M / 24.690M	--
--	2023/Q4	4.252M / 14.262M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 17.328M--

--2024/Q3-- / 35.168M--

--2024/Q228.640M / 37.092M--

--2024/Q127.357M / 24.690M--

--2023/Q44.252M / 14.262M--

Unlock Free Earnings Estimates

Open Account

Atara Biotherapeutics Earnings Reports

Atara Biotherapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 17:11 ET

Atara Biotherapeutics | 10-Q: Q1 2024 Earnings Report

May 9 17:10 ET

Atara Biotherapeutics | 10-K: FY2023 Annual Report

Mar 28 08:44 ET

Atara Biotherapeutics | 10-Q: Q3 2023 Earnings Report

Nov 1, 2023 08:40 ET

Analyst Rating

Updated: Aug 18, 2024

Hold

Buy
40.00%
Hold
40.00%
Sell
20.00%

Price Target

No Data

Heat List

Overall